Nektar Therapeutics reports $229.1M cash and investments as of Jan 31, 2026

NEKTAR THERAPEUTICS

Cash and marketable securities totaled approximately $229.1 million as of January 31, 2026.
Announcement made on February 10, 2026 via a Regulation FD disclosure.
The amounts are estimates based on information available as of the announcement date.
Nektar Therapeutics (ticker: NKTR) listed on the Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.